Web Results
Find Health Information on Healthline
Find Info About:
Healthline is the leading provider of health information.

Diclofenamide - Wikipedia


Diclofenamide (or dichlorphenamide) is a sulfonamide and a carbonic anhydrase inhibitor of the meta-disulfamoylbenzene class.

Dichlorphenamide medical facts from Drugs.com


Physician reviewed dichlorphenamide patient information - includes dichlorphenamide description, dosage and directions.

Keveyis (dichlorphenamide) dosing, indications, interactions ...


Medscape - Periodic paralysis indication dosing for Keveyis (dichlorphenamide), frequency-based adverse effects, comprehensive interactions, ...

dichlorphenamide | C6H6Cl2N2O4S2 - PubChem


Dichlorphenamide is only found in individuals that have used or taken this drug. It is a carbonic anhydrase inhibitor that is used in the treatment of glaucoma.

Keveyis (Dichlorphenamide Tablets): Side Effects, Interactions ...


Aug 24, 2015 ... Dichlorphenamide USP is a white or practically white, crystalline compound with a molecular weight of 305.16. It is very slightly soluble in water ...

Dichlorphenamide (Oral Route) Description and Brand Names ...


Dichlorphenamide is used to treat inherited muscle disorders, such as primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and ...

Prescribing Information (PDF)


KEVEYISTM (dichlorphenamide) tablets, for oral use. Initial U.S. Approval: 1958 ... concomitant use of dichlorphenamide and high-dose aspirin. The concomitant.

Diclofenamide - DrugBank


Jun 13, 2005 ... Pharmacodynamics, Dichlorphenamide is an oral carbonic anhydrase inhibitor indicated for adjunctive treatment of: chronic simple ...

Dichlorphenamide (Keveyis) for Periodic Paralysis | The Medical ...


Apr 11, 2016 ... Dichlorphenamide (Keveyis – Taro), an oral carbonic anhydrase inhibitor, has been approved by the FDA for treatment of primary hypokalemic ...